Growth Metrics

Myomo (MYO) Current Deferred Revenue (2016 - 2025)

Myomo posted quarterly Current Deferred Revenue of $218222.0 for Q4 2025, up 162.55% year-on-year from $83115.0 in Q4 2024, and up 61.95% on a QoQ basis from $134750.0 in Q3 2025.

Myomo (MYO) has 10 years of Current Deferred Revenue data on file, last reported at $218222.0 in Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue rose 162.55% year-over-year to $218222.0; the trailing twelve-month figure through Dec 2025 stood at $218222.0 (up 162.55% YoY), and the FY2025 full-year result was $218222.0, up 162.55% from the prior year.
  • Current Deferred Revenue for Q4 2025 stood at $218222.0, up from $134750.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $218222.0 in Q4 2025 and bottomed at $747.0 in Q1 2023.
  • The 5-year median for Current Deferred Revenue is $12015.0 (2024), against an average of $42802.1.
  • The widest annual swing landed in 2021, when Current Deferred Revenue slumped 94.51%; it then soared 1508.43% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $1500.0 in 2021, then soared by 1276.87% to $20653.0 in 2022, then plunged by 58.8% to $8510.0 in 2023, then jumped by 876.67% to $83115.0 in 2024, then jumped by 162.55% to $218222.0 in 2025.
  • The last three Current Deferred Revenue figures came in at $218222.0 (Q4 2025), $134750.0 (Q3 2025), and $108780.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Myomo 44.63 Mn 26.23 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 218,222.00
Sep 30, 2025 134,750.00
Jun 30, 2025 108,780.00
Mar 31, 2025 129,852.00
Dec 31, 2024 83,115.00
Sep 30, 2024 32,000.00
Jun 30, 2024 12,015.00
Dec 31, 2023 8,510.00
Sep 30, 2023 30,685.00
Jun 30, 2023 747.00
Mar 31, 2023 747.00
Dec 31, 2022 20,653.00
Sep 30, 2022 23,053.00
Jun 30, 2022 2,211.00
Mar 31, 2022 1,899.00
Dec 31, 2021 1,500.00
Sep 30, 2021 1,500.00
Jun 30, 2021 1,500.00
Mar 31, 2021 1,500.00
Dec 31, 2020 4,000.00
Sep 30, 2020 6,684.00
Jun 30, 2020 1,495.00
Mar 31, 2020 27,340.00
Dec 31, 2019 2,913.00
Sep 30, 2019 63,567.00
Jun 30, 2019 40.00
Mar 31, 2019 84,117.00
Dec 31, 2018 106,609.00
Sep 30, 2018 182,515.00
Jun 30, 2018 149,086.00
Mar 31, 2018 142,129.00
Dec 31, 2017 106,718.00
Sep 30, 2017 68,958.00
Jun 30, 2017 81,560.00
Dec 31, 2016 67,263.00